TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07001748: Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Sponsor: ECOG-ACRIN Cancer Research Group · Phase: PHASE2/PHASE3 · Area: ONCOLOGY · Target Enrollment: 148 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$4,340,028

Rescue Site Savings

+$2,874,564

Unlock Full NCT07001748 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07001748 Rescue Dossier →